July 14, 2020
Penumbra Appoints Medical and Scientific Leadership
July 14, 2020—Penumbra, Inc. announced appointments for two newly created positions: Corey L. Teigen, MD, as Chief Scientific Officer and James F. Benenati, MD, as Chief Medical Officer.
Dr. Teigen joins Penumbra immediately and will contribute his extensive scientific and clinical expertise to ongoing and future research and development efforts. Dr. Benenati will join Penumbra on September 1, 2020, and will contribute to clinical and medical affairs strategies and advise on global commercialization and market development activities.
“In my radiology practice, I’ve seen firsthand the challenges medical practitioners face while treating difficult medical conditions,” stated Dr. Teigen in the announcement. “At Penumbra, I have a profound opportunity to change the course of health care delivery for people living with vascular disease. I feel privileged to join Penumbra’s unparalleled group of talented engineers and leaders, and I look forward to contributing my scientific knowledge to help solve challenging medical problems.”
Dr. Benenati commented, “I’m excited to join Penumbra at this very important time for the company, where it’s poised for growth as it moves into the next generation of intelligent clot removal and expands into rehabilitation with the recent launch of the Real system. Penumbra has changed the landscape of health care by providing truly innovative solutions for a wide realm of medical challenges. In this next phase, Penumbra is set to broaden its reach on a global scale, and I am thrilled to join this excellent team and help accelerate the impact of its products.”